Robaxin and Enlarged heart - a phase IV clinical study of FDA data

Summary:

Enlarged heart is reported as a side effect among people who take Robaxin (methocarbamol), especially for people who are male, 60+ old, also take Prilosec, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Enlarged heart when taking Robaxin. It is created by eHealthMe based on reports of 8,252 people who have side effects when taking Robaxin from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Enlarged heart?

Enlarged heart is found to be associated with 1,443 drugs and 1,667 conditions by eHealthMe. Check the latest studies of Enlarged heart.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

8,252 people reported to have side effects when taking Robaxin.
Among them, 37 people (0.45%) have Enlarged heart.

Among these 37 people:

What is the gender of people who have Enlarged heart when taking Robaxin? *

female: 45.95 %
male: 54.05 %

What is the age of people who have Enlarged heart when taking Robaxin? *

What are other drugs people take besides Robaxin? *

What are other side effects people have besides Enlarged heart? *

Stress And Anxiety: 23 people, 62.16%
Heart Attack: 22 people, 59.46%
Depression: 22 people, 59.46%
Fainting (loss of consciousness and postural tone): 22 people, 59.46%
Cardiac Failure Congestive: 22 people, 59.46%
Nausea (feeling of having an urge to vomit): 21 people, 56.76%
Mitral Valve Incompetence (inefficient heart valve): 21 people, 56.76%
Oedema Peripheral (superficial swelling): 20 people, 54.05%
Pain: 20 people, 54.05%
Joint Pain: 20 people, 54.05%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 40.54%
Bone Disorder: 13 people, 35.14%
Depression: 8 people, 21.62%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 16.22%
Headache (pain in head): 4 people, 10.81%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.11%
Arrhythmias (irregular heartbeat): 3 people, 8.11%
Stable Angina (a constant chest pain): 3 people, 8.11%
Metastases To Bone (cancer spreads to bone): 2 people, 5.41%
Osteoporosis (bones weak and more likely to break): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Enlarged heart?

- Check whether Enlarged heart is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robaxin:

Robaxin (9,109 reports)

Enlarged heart treatments and more:

Enlarged heart (20,022 reports)

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enlarged heart:

Enlarged heart (1,443 drugs)

Browse all the conditions that are associated with Enlarged heart:

Enlarged heart (1,667 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.